Markets:

Overview

News

Currencies

International

Treasuries

Minerva Neurosciences, Inc - Common Stock (NQ:NERV)

2.460 -0.060 (-2.38%)

Delayed Quote Updated: 12:47 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Minerva Neurosciences, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

US Stocks Rise; Dow Gains 100 Points ↗

December 28, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.

Via Benzinga

Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

December 28, 2022

From Minerva Neurosciences, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 06, 2022

Gainers

Via Benzinga

Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates

November 14, 2022

EQNX::TICKER_START (NASDAQ:SAGE),NASDAQ:NERV),(NASDAQ:ATAI),(NYSE:CYBN),(TSXV:MRVL),(NEO:CYBN), EQNX::TICKER_END

Via FinancialNewsMedia

Topics Retirement

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 ↗

November 10, 2022

Upgrades

Via Benzinga

Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates

November 09, 2022

Company To Host Live Webcast Today at 8:30 a.m. ET

From Minerva Neurosciences, Inc

Via GlobeNewswire

Minerva Neurosciences Shares Sink On Regulatory Setback For Schizophrenia Candidate ↗

October 17, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 09, 2022

Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings...

Via Benzinga

Minerva Neurosciences to Report Third Quarter 2022 Financial Results and Business Updates on November 9, 2022

November 02, 2022

From Minerva Neurosciences, Inc

Via GlobeNewswire

Why IBM Shares Are Trading Higher; Here Are 21 Stocks Moving Premarket ↗

October 20, 2022

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) rose 20.9% to $0.1063 in pre-market trading after dipping 26% on Wednesday. COMSovereign recently announced receipt of Nasdaq listing determination.

Via Benzinga

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

Dow Rises Over 2%; S&P 500 Up 100 Points ↗

October 17, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 300 points on Monday.

Via Benzinga

Virgin Orbit And 4 More Short Squeeze Stocks That Could Soar This Week — Including A Stock Moving Up 968 Positions ↗

October 17, 2022

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 17, 2022

Gainers

Via Benzinga

Nasdaq Jumps 300 Points; Bank of America Tops Q3 Estimates ↗

October 17, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Monday.

Via Benzinga

Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session ↗

October 17, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday.

Via Benzinga

GLSI, AVTE: The Top 5 Short Squeeze Stocks to Watch This Week ↗

October 17, 2022

Short-squeeze stocks continue to be a big deal for speculative traders and we're helping them out with a list to keep in mind this week!

Via InvestorPlace

Looking Into Minerva Neurosciences's Recent Short Interest ↗

October 17, 2022

Minerva Neurosciences's (NASDAQ:NERV) short percent of float has fallen 47.4% since its last report. The company recently reported that it has 573 thousand shares sold short, which is 14.49% of all...

Via Benzinga

US Stocks Open Higher; Dow Surges 500 Points ↗

October 17, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 500 points on Monday.

Via Benzinga

Minerva Neurosciences Receives Refusal to File Letter from FDA for its New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

October 17, 2022

From Minerva Neurosciences, Inc

Via GlobeNewswire

TOP Ships, Weber And 3 More Short Squeeze Stocks That Could Soar This Week ↗

October 10, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the...

Via Benzinga

Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday ↗

October 12, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.

Via Benzinga

TOPS, SURG: The Top 5 Short Squeeze Stocks This Week ↗

October 10, 2022

Short squeeze stocks are still popular with speculative traders and that has us going over the top ones to keep an eye on this week!

Via InvestorPlace

How Is The Market Feeling About Minerva Neurosciences? ↗

September 28, 2022

Minerva Neurosciences's (NASDAQ:NERV) short percent of float has fallen 31.87% since its last report. The company recently reported that it has 1.09 million shares sold short, which is 27.55% of all...

Via Benzinga

10 Short Squeeze Candidates That May Soar: Minerva Neurosciences, FaZe, Getty Images And More ↗

September 26, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.

Via Benzinga

NERV, FAZE: The Top 5 Short Squeeze Stocks This Week ↗

September 26, 2022

Short squeeze stocks are still worth tracking as traders look for potential gains this week and we've got a list of potential targets!

Via InvestorPlace

NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week ↗

September 19, 2022

Traders continue to show interest in short squeeze stocks this week as they seek out likely targets that will run higher.

Via InvestorPlace

5 Short Squeeze Stocks That Could Soar: NeruoBo Pharmaceuticals, FaZe Holdings And More ↗

September 19, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 14, 2022

Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.

Via Benzinga

Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday ↗

September 01, 2022

Gainers

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Minerva Neurosciences, Inc - Common Stock (NQ:NERV)

All News about Minerva Neurosciences, Inc - Common Stock

Starting at /week.